VivoSeq
Other

Postpartum

0

Pipeline Programs↗

5

Active Trials↗

1

Companies Involved↗

Postpartum is an early-stage landscape with 0 programs across 1 company. The most active players are YI-JU TSAI.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Y

YI-JU TSAI

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Recruiting4 · 67%
Completed1 · 17%
Not yet recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

Evaluating the Effectiveness of an Integrated Group Postpartum and Well-child Care Model on Maternal and Child Health Outcomes
Recruiting·JJohns Hopkins University·Preclinical·NCT07414901·1,125 enrolled
Comparison of Diaphragmatic Breathing Exercise and Pelvic Stabilization Exercise in Postpartum Women With Pregnancy-related Pelvic Girdle Pain: A Real-time Telehealth-based Intervention
Recruiting·YYI-JU TSAI·Preclinical·NCT06284278·60 enrolled
Use of Early Time-restricted Eating to Promote Weight Loss and Improve Cardiometabolic Health in Postpartum Women
Recruiting·UUniversity of Alabama at Birmingham·Preclinical·NCT06491537·60 enrolled
Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis
Recruiting·UUniversity of Valencia·Preclinical·NCT07419399·48 enrolled
THE EFFECTS OF HYBRID FAMILY PLANNING COUNSELING IN THE POSTPARTUM PERIOD ON MATERNAL HEALTH: A LONGITUDINAL STUDY
Not yet recruiting·Gaziantep Islam Science and Technology University·Preclinical·NCT07667374·96 enrolled
Prevention of Iron Deficiency Anemia Post-delivery (PRIORITY Trial): A Randomized Controlled Trial of the Global Network for Women's and Children's Health Research
Completed·NNICHD Global Network for Women's and Children's Health·Phase 3·NCT05590260·4,857 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)